达丁类药物的纳米分子治疗度通过刺激L型通道迅速诱导大脑动脉血管收缩
Farzana Zerin1, Nazia Hoque2, Sreelakshmi N Menon1
1Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA, USA.
Biochemical pharmacology
|May 4, 2025
概括
通过直接激活CaV1.2通道,他类药物迅速收缩大脑动脉,这可能解释了他类药物引起的记忆丧失. 这种效应在雌性大鼠中不那么明显,并且依赖于流入.
科学领域:
- 心血管药理学心血管药理学
- 神经药理学神经药理学
- 脑血管生理学 脑血管生理学
背景情况:
- 类药物是被广泛处方的降胆固醇药物.
- 可逆性记忆丧失是他类药物治疗的一种报告的副作用,但其机制尚不清楚.
- 对于他类药物对大脑动脉收缩性的直接影响是未知的.
研究的目的:
- 为了研究他类药物对大鼠大脑动脉的急性血管作用.
- 阐明基因类药物诱导的大脑血管度变化的基础分子机制.
- 探索他类药物的血管效应和认知副作用之间的潜在联系.
主要方法:
- 压力肌图被用来评估老鼠大脑动脉的收缩性.
- 实验涉及不同细胞外的度和使用药理学阻断剂的CaV1.2通道.
- 使用siRNA淘汰和动脉生物化来研究CaV1.2通道的参与.
主要成果:
- 治疗度的他类药物诱导了大鼠大脑动脉的快速血管收缩,主要是男性.
- 这种影响独立于内皮和胆固醇水平.
- 血管收缩依赖于细胞外,并通过光滑肌肉细胞中的CaV1.2通道进行介导,而不会改变通道的表达或功能.
结论:
- 类药物直接刺激大脑动脉平滑肌肉中的CaV1.2通道,导致迅速的血管收缩.
- 这种机制为与他类药物相关的记忆障碍提供了潜在的解释.
- 这些发现表明,个人对他类药物的反应可能因性别和并发药物等因素而异.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
394
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
394
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
465
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
465
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
392
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
392
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
692
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
692
Local Anesthetics: Mechanism of Action
2.1K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.1K


